Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trinase for Post-Operative Pain in Symptomatic Irreversible Pulpitis
NCT07239505Completed
- Sponsor
- Fayoum University
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in irreversible pulpitis and postoperative pain comparing Trinase group with Placebo group (2 arms). Primary endpoint: Post-operative pain intensity at 48 hours. Started Aug 2025; status: completed.
02
Drugs
trypsin + bromelain + rutoside
03
Conditions
irreversible pulpitispostoperative pain
Beyond the preview
Go deeper on NCT07239505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07239505.